Position in NVS
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$879,199
+$22,272 QoQ
Shares Held
5,610
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#665
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NEVILLE RODIE & SHAW INC holds $104,588,687 across 10 Drug Manufacturers - General names. NVS ranks #8 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
168,188 | $42,714,706 | |
| 2 | ABBV |
AbbVie Inc.
|
88,895 | $22,369,537 | |
| 3 | LLY |
ELI LILLY & Co
|
17,226 | $20,661,382 | |
| 4 | MRK |
Merck & Co., Inc.
|
87,699 | $11,269,321 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
39,489 | $2,275,356 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
14,844 | $1,875,390 | |
| 7 | PFE |
Pfizer Inc
|
64,658 | $1,556,964 | |
| 8 | NVS |
Novartis AG
This page
|
5,610 | $879,199 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $879,199 | 5,610 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $856,927 | 5,610 | Shares | Sole | 2026-04-01 | |
| 2025-12-31 | $883,746 | 6,410 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $822,018 | 6,410 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $775,674 | 6,410 | Shares | Sole | 2025-07-02 | |
| 2025-03-31 | $720,160 | 6,460 | Shares | Sole | 2025-04-01 | |
| 2024-12-31 | $628,622 | 6,460 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $743,029 | 6,460 | Shares | Sole | 2024-10-01 | |
| 2024-06-30 | $687,731 | 6,460 | Shares | Sole | 2024-07-01 | |
| 2024-03-31 | $624,875 | 6,460 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $652,266 | 6,460 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $1,009,636 | 9,912 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $1,002,238 | 9,932 | Shares | Other | 2023-07-06 | |
| 2023-03-31 | $913,744 | 9,932 | Shares | Other | 2023-04-04 | |
| 2022-12-31 | $901,031 | 9,932 | Shares | Other | 2023-01-03 | |
| 2022-09-30 | $754,931 | 9,932 | Shares | Other | 2022-10-04 | |
| 2022-06-30 | $839,551 | 9,932 | Shares | Other | 2022-07-06 | |
| 2022-03-31 | $871,533 | 9,932 | Shares | Other | 2022-04-05 | |
| 2021-12-31 | $868,752 | 9,932 | Shares | Other | 2022-01-05 | |
| 2021-09-30 | $812,238 | 9,932 | Shares | Other | 2021-10-06 | |
| 2021-06-30 | $906,195 | 9,932 | Shares | Other | 2021-07-06 | |
| 2021-03-31 | $848,987 | 9,932 | Shares | Other | 2021-04-08 | |
| 2020-12-31 | $937,878 | 9,932 | Shares | Other | 2021-03-04 | |
| 2020-09-30 | $863,686 | 9,932 | Shares | Other | 2020-10-01 | |
| 2020-06-30 | $867,460 | 9,932 | Shares | Other | 2020-07-15 | |
| 2020-03-31 | $818,893 | 9,932 | Shares | Other | 2020-04-01 | |
| No filing history on record for this holder in this stock. | ||||||